Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
40,261,661
-
Share change
-
+614,924
-
Total reported value
-
$1,300,363,433
-
Put/Call ratio
-
104%
-
Price per share
-
$32.30
-
Number of holders
-
178
-
Value change
-
+$16,595,121
-
Number of buys
-
86
-
Number of sells
-
88
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2016
As of 31 Dec 2016,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,261,661 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, HealthCor Management, L.P., GILDER GAGNON HOWE & CO LLC, DARUMA CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., and Clearbridge Investments, LLC.
This page lists
178
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.